Abstract:Manganese porphyrins realize cyclic guanosine monophosphate‐adenosine monophosphate synthase (cGAS)‐stimulator of interferon gene (STING) pathway activation. The high Mn2+ delivery efficiency and reactive oxygen species generation capability enable this function. The well‐designed delivery system further enhances their accuracy and efficacy to facilitate cancer immunotherapy. Immunotherapy has emerged as a highly effective therapeutic strategy for cancer treatment. Cyclic guanosine monophosphate‐adenosine monophosphate synthase (cGAS)‐stimulator of interferon gene (STING) pathway activation facilitates tumor‐associated macrophage (TAM) polarization toward M1 phenotype, and Mn2+ are effective agents for this pathway activation. However, the high in vivo degradation rate and toxicity of Mn2+ hamper clinical application of immunotherapy. Here, this work has newly synthesized and screened manganese porphyrins for Mn2+ transport, referred to as photo‐STING agonists (PSAs), and further encapsulate them into core‐shell nanoparticles named Rm@PP‐GA with dual specificity for tumor tissue and TAMs. Not only do PSAs achieve higher Mn2+ delivery efficiency compared to Mn2+, but they also generate reactive oxygen species under light exposure, promoting mitochondrial DNA release for cGAS‐STING pathway activation. In Rm@PP‐GA, globin and red blood cell membranes (Rm) are used for erythrocyte efferocytosis‐mimicking delivery. Rm can effectively prolong the in vivo circulation period while globin enables PSAs to be taken up by TAMs via CD163 receptors. After Rm rupture mediated by perfluorohexane in nanoparticles under ultrasonication, drugs are specifically released for TAM repolarization. Further, dendritic cells mature, as well as T lymphocyte infiltrate, both of which favor tumor eradication. Therefore, cancer immunotherapy is optimized by novel PSAs delivered by erythrocyte efferocytosis‐mimicking delivery pattern.

Self-assembly of a ruthenium-based cGAS-STING photoactivator for carrier-free cancer immunotherapy

Bioorthogonal Guided Activation of Cgas‐STING by Aie Photosensitizer Nanoparticles for Targeted Tumor Therapy And Imaging

Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy

Activation of cGAS-STING pathway by a mitochondrial DNA-targeted emissive rhodium(III) metallointercalator

Mitochondria-targeting nanozyme for catalytical therapy and radiotherapy with activation of cGAS-STING

Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy.

Simultaneous Activation of Pyroptosis and cGAS‐STING Pathway with Epigenetic/ Photodynamic Nanotheranostic for Enhanced Tumor Photoimmunotherapy

Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth

Tumor-responsive Covalent Organic Polymeric Nanoparticles Enhancing STING Activation for Cancer Immunotherapy

cGAS‐STING Pathway Activation and Systemic Anti‐Tumor Immunity Induction via Photodynamic Nanoparticles with Potent Toxic Platinum DNA Intercalator Against Uveal Melanoma

Photoactivated DNA Assembly and Disassembly for On-Demand Activation and Termination of cGAS-STING Signaling.

Virus-Like Particle-Induced cGAS-STING Activation and AIM2 Inflammasome-Mediated Pyroptosis for Robust Cancer Immunotherapy.

Novel Photo‐STING Agonists Delivered by Erythrocyte Efferocytosis‐Mimicking Pattern to Repolarize Tumor‐Associated Macrophages for Boosting Anticancer Immunotherapy

Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy

Branched Polymer‐Based Redox/Enzyme‐Activatable Photodynamic Nanoagent to Trigger STING‐Dependent Immune Responses for Enhanced Therapeutic Effect

Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle

An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy

pH‐Responsive, Self‐Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death

A Type I Photosensitizer-Polymersome Boosts Reactive Oxygen Species Generation by Forcing H-Aggregation for Amplifying STING Immunotherapy

Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy

Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications